<DOC>
	<DOCNO>NCT02962245</DOCNO>
	<brief_summary>The research aim find whether berberine reduce annual recurrence rate ulcerative colitis remission . A total 238 patient ulcerative colitis remission randomly divide two groups.One receive regular treatment , group receive extra oral berberine 300 mg three time daily year . The end study every patient disease recurrence ( Mayo Clinic score 3 point ) . The primary analysis annual recurrence rate , endoscopy Mayo Clinic disease activity index score baseline final assessment .</brief_summary>
	<brief_title>Efficacy Treatment With Berberine Maintain Remission Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>1 . Diagnosis ulcerative colitis ( accord second European evidencebased consensus diagnosis management ulcerative colitis ) ; 2 . Disease remission ulcerative colitis ( total Mayo Clinic score 2 point less endoscopic score 1 point less ) ; 3 . Diagnosis moderate severe ulcerative colitis within 3 month ( total Mayo Clinic score 612 point ) 1 . Prior bowel resection surgery ; 2 . Women plan actual pregnancy lactation study period ; 3 . Patients allergic berberine ; 4 . History disease would interfere participation trial , include malignant disease , bleed disorder , active gastric active duodenal ulcer , autoimmune disease , mental emotional disorder ; 5 . Take follow treatment : Unstable dose 5ASA drug ( oral and/or rectal route ) within 14 day prior screen ; Unstable dose immunomodulating/suppressive agent AntiTNF therapy within 3 month prior screen ; Traditional Chinese Medicine treatment UC ( pharmaceutical form ) within 7 day prior screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Ulcerative Colitis</keyword>
	<keyword>Berberine</keyword>
</DOC>